Westlake Village-based Cynvenio Biosystems raised $25.5 million in Series B equity financing Wednesday. Cynvenio’s LiquidBiopsy technology allows doctors to access populations of rare cancer cells in whole blood. At the same time, it allows doctors to analyze complex characteristics of cancers in a single blood sample. The investment was led by Livzon Pharmaceutical Group, which Read More →Read More →
Loading...You are here: Home > 'Livzon'